跳至主要内容
临床试验/PACTR202407549032623
PACTR202407549032623尚未招募2 期

Effect of amlodipine on oxidative stress among adult Nigerian hypertensives: an exploratory randomised control trial (AMLOX-NH)

Ejiroghene Umuerri0 个研究点目标入组 44 人开始时间: 2024年7月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Patients aged 35 - 65 years
  • Systolic blood pressure of 140mmHg and above and less than 180mmHg

排除标准

  • Participants with severe hypertension (BP =180/110mmHg)
  • Patients with suspected secondary hypertension
  • Participants with a history of use of antihypertensive medications, statins, anti-platelets, and vitamin C supplements in the past three months before the screening date.
  • Participants with eGFR<35ml/min/1.73m2, congestive cardiac failure, transient ischaemic attack or stroke, acute or chronic coronary syndrome, and hepatic failure.
  • Participants with mental impairment capable of interfering with the conduct of the study.
  • Pregnant women and women of childbearing age who are not on effective contraception.
  • Unwillingness to provide written informed consent.

研究者

发起方
Ejiroghene Umuerri

相似试验